Related Experiment Video
Updated: Jun 15, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Drug-induced liver injury (DILI) is a common adverse drug reaction. While some DILI is directly toxic, many cases are idiosyncratic and may have dose-dependent factors, requiring careful diagnosis and management.
Area of Science:
- Hepatology
- Clinical Pharmacology
- Toxicology
Background:
- Drug-induced liver injury (DILI) is a significant adverse drug reaction.
- DILI presents with diverse clinical and histological features, often mimicking other liver diseases.
- While paracetamol toxicity is directly toxic, other DILI cases exhibit unpredictable, idiosyncratic patterns.
Purpose of the Study:
- To highlight the importance of considering DILI in patients with liver dysfunction.
- To discuss the dose-dependent component of idiosyncratic DILI.
- To outline diagnostic and management strategies for DILI.
Main Methods:
- Review of clinical presentations and histological findings in DILI.
- Analysis of dose-dependency in idiosyncratic drug reactions.
- Discussion of diagnostic challenges and exclusion criteria for DILI.
Main Results:
- DILI can mimic any known liver disease, lacking pathognomonic features.
- Idiosyncratic DILI, initially considered dose-independent, often shows a dose-dependent component.
- Diagnosis of DILI is primarily achieved through exclusion of other causes.
Conclusions:
- Physicians must maintain a high index of suspicion for DILI in patients with liver dysfunction.
- Discontinuation of the offending drug is crucial.
- Hospitalization and consideration for liver transplantation are necessary for severe DILI cases with jaundice or coagulopathy.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Dose-Dependent Reactions
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Drug Toxicity: Overview

